GNMLF (Genomma Lab InternacionalB de CV) Market Cap : $1,163.4 Mil (As of Mar. 23, 2025)

View and export this data going back to 2012. Start your Free Trial

What is Genomma Lab InternacionalB de CV Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genomma Lab InternacionalB de CV's share price for the quarter that ended in Dec. 2024 was $1.27. Genomma Lab InternacionalB de CV's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 944.9 Mil. Therefore, Genomma Lab InternacionalB de CV's market cap for the quarter that ended in Dec. 2024 was $1,200.0 Mil.

Genomma Lab InternacionalB de CV's quarterly market cap increased from Jun. 2024 ($925.4 Mil) to Sep. 2024 ($1,067.7 Mil) and increased from Sep. 2024 ($1,067.7 Mil) to Dec. 2024 ($1,200.0 Mil).

Genomma Lab InternacionalB de CV's annual market cap declined from Dec. 2022 ($807.3 Mil) to Dec. 2023 ($796.3 Mil) but then increased from Dec. 2023 ($796.3 Mil) to Dec. 2024 ($1,200.0 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genomma Lab InternacionalB de CV's Enterprise Value for Today is $1,364.4 Mil.

Genomma Lab InternacionalB de CV Market Cap Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Market Cap Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Market Cap

Get a 7-Day Free Trial

971.96

1,049.03

807.29

796.27

1,199.97

Genomma Lab InternacionalB de CV Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Market Cap	Get a 7-Day Free Trial															796.27	942.36	925.40	1,067.69	1,199.97

Competitive Comparison of Genomma Lab InternacionalB de CV's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomma Lab InternacionalB de CV's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Market Cap distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Market Cap falls into.

Genomma Lab InternacionalB de CV Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Genomma Lab InternacionalB de CV's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )	=	Share Price (A: Dec. 2024 )	*	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	$1.27	*	944.862
	=	$1,200.0

Genomma Lab InternacionalB de CV's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )	=	Share Price (Q: Dec. 2024 )	*	Shares Outstanding (EOP) (Q: Dec. 2024 )
	=	$1.27	*	944.862
	=	$1,200.0

Genomma Lab InternacionalB de CV (OTCPK:GNMLF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Genomma Lab InternacionalB de CV Market Cap Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

LABB:Mexico GEKA:Germany

Address

Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.